Possible Alzheimer’s Drug Advancements; Bernard-Henri Lévy On Syria

Possible Alzheimer’s Drug Advancements; Bernard-Henri Lévy On Syria

Biotech company Biogen has announced plans to seek experimental approval for an Alzheimer’s drug that appeared to fail in clinical trials earlier this year. STAT reporter Sharon Begley has the latest. Also, French philosopher Bernard-Henri Lévy, a vocal advocate for the Kurds, discusses the recent developments in Syria.